Published April 2021 | Version v1
Journal article

Integrating site-specific peptide reporters and targeted mass spectrometry enables rapid substrate-specific kinase assay at the nanogram cell level

  • 1. Department of Chemistry, National Tsing Hua University, No. 101, Section 2, Kuang-Fu Road, Hsinchu, 30013 (China)
  • 2. Institute of Chemistry, Academia Sinica, No. 128, Section 2, Academia Road, Taipei, 115 (China)
  • 3. Molecular Science and Technology Program, Taiwan International Graduate Program, Academia Sinica and National Tsing Hua University (China)
  • 4. Department of Internal Medicine, National Taiwan University College of Medicine, Taipei (China)
  • 5. Institute of Chemistry and the Center for Nanoscience and Nanotechnology, The Hebrew University of Jerusalem, Safra Campus, Givat Ram, Jerusalem, 91904 (Israel)
  • 6. Department of Chemistry, National Taiwan University, No. 1, Section 4, Roosevelt Road, Taipei, 10617 (China)

Description

Highlights: • Peptide reporter-assisted MRM-MS enables substrate-specific kinase activity profiling. • Assay provides ultrahigh sensitivity at ng cell lysate and rapid analysis in 3 h. • The quantitation results demonstrated good accuracy and precision. • Substrate phosphorylation in NSCLC cells reveals association with drug resistance. • The assay is a generic method easily applied for novel phosphorylation sites. Dysregulation of phosphorylation-mediated signaling drives the initiation and progression of many diseases. A substrate-specific kinase assay capable of quantifying the altered site-specific phosphorylation of its phenotype-dependent substrates provides better specificity to monitor a disease state. We report a sensitive and rapid substrate-specific kinase assay by integrating site-specific peptide reporter and multiple reaction monitoring (MRM)-MS platform for relative and absolute quantification of substrate-specific kinase activity at the sensitivity of nanomolar kinase and nanogram cell lysate. Using non-small cell lung cancer as a proof-of-concept, three substrate peptides selected from constitutive phosphorylation in tumors (HDGF-S165, RALY-S135, and NRD1-S94) were designed to demonstrate the feasibility. The assay showed good accuracy (−1 min−1, while RALY-S135 and NRD1-S94 showed 4- and 20-fold higher activity at the sensitivity of 25 ng and 5 ng lysate, respectively, suggesting different endogenous kinases for each substrate peptide. Without the conventional shotgun phosphoproteomics workflow, the overall pipeline from cell lysate to MS data acquisition only takes 3 h. The multiplexed analysis revealed differences in the phenotype-dependent substrate phosphorylation profiles across six NSCLC cell lines and suggested a potential association of HDGF-S165 and NRD1-S94 with TKI resistance. With the ease of design, sensitivity, accuracy, and reproducibility, this approach may offer rapid and sensitive assays for targeted quantification of the multiplexed substrate-specific kinase activity of small amounts of sample.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.aca.2021.338341

Additional details

Identifiers

DOI
10.1016/j.aca.2021.338341;
PII
S0003267021001677;

Publishing Information

Journal Title
Analytica Chimica Acta
Journal Volume
1155
Journal Page Range
vp.
ISSN
0003-2670
CODEN
ACACAM

Optional Information

Copyright
Copyright (c) 2021 The Authors. Published by Elsevier B.V.